Risperidone-induced galactorrhea

Schreiber, S.; Segman, Ronnen H.
April 1997
Psychopharmacology;1997, Vol. 130 Issue 3, p300
Academic Journal
Reports a case of risperidone-induced hyperprolactinemia and galactorrhea. Clinical features of the subject; Treatment; Background on risperidone.


Related Articles

  • Domperidone.  // Reactions Weekly;6/22/2013, Issue 1458, p20 

    The article describes the case of a 19-year-old woman who developed hyperprolactinaemia and galactorrhoea while receiving domperidone for vomiting.

  • Risperidone.  // Reactions Weekly;7/28/2012, Issue 1412, p41 

    The article describes the case of a 29-year-old man with schizophrenia who developed hyperprolactinaemia during treatment with risperidone.

  • Hyperprolactinaemia with amisulpride. Raj, Rajnish; Sidhu, Balwant Singh // Indian Journal of Psychiatry;2008, Vol. 50 Issue 1, p54 

    Amisulpride, a substituted benzamide derivative, is a second-generation antipsychotic that preferentially binds to D2/D3 receptors in limbic rather than striatal structures. High dosage preferentially antagonizes postsynaptic receptors, resulting in reduced dopamine transmission; and low dosage...

  • Risperidone/zuclopenthixol.  // Reactions Weekly;12/11/2010, Issue 1331, p28 

    The article describes the clinical cases of five women, diagnosed with schizophrenic exacerbations, who developed symptomatic hyperprolactinaemia while under zuclopenthixol or risperidone treatment regimen.

  • Risperidone.  // Reactions Weekly;10/9/2010, Issue 1322, p26 

    The article describes the case of a woman in her 20s who developed hyperprolactinaemia while undergoing treatment with risperidone.

  • Antipsychotics and high prolactin.  // WHO Drug Information;2001, Vol. 15 Issue 2, p81 

    Reports that the New Zealand Medicines and Medical Devices Safety Authority has recommended reducing the dosage, or changing to an atypical antipsychotic agent, when patients receiving typical antipsychotics or risperidone experience symptomatic hyperprolactinemia. Circumstances wherein...

  • Risperidone.  // Reactions Weekly;1/12/2013, Issue 1434, p55 

    The article describes the case of a 39-year-old woman who received risperidone but she developed hyperprolactinaemia and iopathic granulomatous mastitis during treatment.

  • Risperidone.  // Reactions Weekly;2/26/2011, Issue 1340, p35 

    The article describes the clinical cases of nine men who experienced hyperprolactinemia and sexual dysfunction while under risperidone treatment regimen for chronic schizophrenia.

  • Quetiapine/risperidone.  // Reactions Weekly;7/20/2013, Issue 1462, p28 

    The article presents a case study about the development of hyperprolactinaemia in a 53-year-old man after receiving risperidone and quetiapine.


Read the Article

Other Topics